Firstsource Solutions Ltd Q3 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/hsgz1f8om368lbu30m6ipmh9.pdf

Key Takeaways


Revenue Growth & Guidance

Idnani: "We have won 13 large deals in the first nine months of FY26, versus 14 wins in the entire FY25 and close to double the number of wins in FY24. Not just that, while previously our large deals almost always came from existing clients, six of the large deals this year so far came from new logos versus 5 in FY25."

Margin Trajectory & the Nearshore Pivot

Idnani: "Our UK onshore headcount has come down by about 40% over the last four quarters, while the corresponding headcount in South Africa during the same period is up by about 50%."

Vertical & Geographic Performance

Vertical / GeographyTrendCommentary
BFSI▲ 9% YoYClients prioritising regulatory adherence, CX and cost efficiency; mortgage transformation offerings resonating amid high rates; pipeline among strongest in recent quarters with at least one large deal in advanced closure.
Healthcare▲ 6% YoYPayers and providers at different transformation stages; dedicated leadership roles created for both segments; large-deal ramp-ups progressing; planned provider account rationalisation may weigh on optical growth short-term.
CMT▲ 14% YoYSeasonally soft Q3 due to holidays; growth driven by consumer tech and AI-integration solutions; pipeline well-balanced and healthy.
Diverse Portfolio▲ 21% YoYIncludes utilities and retail, mainly UK; Pastdue Credit adds large logos in utilities; retail expanding through footprint and renewal add-ons; seasonal retail strength in Q3 partly offset by Technology weakness.
North America▲ 13% YoYBroad-based momentum across three core verticals; incubating new growth in Canada and replicating UK capabilities.
Europe▲ 2% YoYAccelerating offshore/nearshore delivery; pipeline up ~40% over four quarters; renewed UK banking contract as primary onshore and offshore partner; three large deals won.
Australia▲ GrowthWinning additional business with existing clients; one of the largest deal wins in Q3.
Idnani: "This is a tweet. The President tweets a bunch of things and details of implementation, compliance requirements, et cetera are still awaited."

Healthcare: CMS Uncertainty & Strategic Bets

Idnani: "Our view is that, this should lead to not just more outsourcing, but also more offshoring and clients looking for more transformational programs that give them a structural uplift in their cost structure. So, we think it is a net positive in terms of a tailwind."

Deal Wins, Pipeline & Strategic Logos


Acquisitions & Capital Allocation


Guidance & Commitments

CommitmentSpecificsTimeline
Organic CC revenue growth13% to 14% rangeFY26
CC revenue growth incl. acquisitions14.5% to 15.5% rangeFY26
EBIT margin11.5% to 12% range (raised)FY26
Annual margin expansion50–75 bps per year toward 14–15% bandFY26–FY28
Healthcare provider account rationalisationOptical growth drag from trimming low-margin accountsNext 2–3 quarters
Non-linear revenue disclosureMore detail on outcome-based commercial structuresStarting next fiscal year
Tax rateWithin 1% of current guided rate of 21%Ongoing

Key Metrics

MetricQ3 FY26
Revenue₹2,440 cr (US$274 mn), +16.2% YoY in rupee terms, +10.2% YoY in US$ terms, +10.6% YoY in constant currency
Operating profit (EBIT)₹290 cr, +24.9% YoY
EBIT margin11.9%, +40 bps QoQ, +80 bps over last four quarters
Adjusted profit after tax₹200 cr, +26% YoY
Effective tax rate21% for Q3, 20% for nine months
FY26 constant currency revenue growth guidance (organic)13% to 14%
FY26 constant currency revenue growth guidance (incl. acquisitions)14.5% to 15.5%
FY26 EBIT margin guidance11.5% to 12%, raised from 11.25% lower end
Large deals won5 in Q3, fourth straight quarter of four or more; 13 in 9MFY26 vs 14 in all of FY25
Deal pipelineOver US$1 bn
Headcount36,689, net increase of ~690 QoQ
Trailing 12-month attrition27.4%, improved ~10 ppt over last 8 quarters
Offshore revenue mix43.4%, up ~13–14 ppt over last 9–10 quarters
DSO67 days vs 69 days in Q2
OCF to EBITDA93% for Q3, 86% for nine months
FCF to adjusted PAT164% for Q3, 159% for nine months
Net debt₹1,170 cr as of Dec 31, 2025 vs ₹1,080 cr as of Sep 30, 2025
Interim dividend₹5.5 per share
BFSI vertical constant currency revenue growth9% YoY, flat sequentially
Healthcare vertical constant currency revenue growth6% YoY, flat sequentially
CMT vertical constant currency revenue growth14% YoY, +2% QoQ
Diverse portfolio constant currency revenue growth21% YoY, +37% QoQ
North America constant currency revenue growth13% YoY, +1% QoQ
Europe constant currency revenue growth2% YoY, +14% QoQ
Clients with >US$1m revenue run-rate141, addition of 34 over Q3FY25
One-time charge (gratuity/leave encashment provisioning)₹91.4 cr
Exceptional item (legacy investment diminution)₹8.8 cr
Tail account rationalization impact on FY26 revenue growth~50 bps